Anthera Pharmaceuticals Provides Business Update and Reports 2017 Second Quarter Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/25/2026

1. QCOM
2. MU
3. CBRS
4. HTZ
5. FDX
6. USO
7. SPY
8. LAES
9. KBH
10. HON

Go back to Anthera Pharmaceuticals Provides Business Update and Reports 2017 Second Quarter Financial Results

Anthera Pharma (ANTH) PT Lowered to $1.75 at Jefferies Following 2Q

August 11, 2017 8:08 AM EDT

Jefferies lowered its price target on Anthera Pharma (NASDAQ: ANTH) to $1.75 (from $2.25) while maintaining a Hold rating following the company's 2Q. ANTH reported EPS of $0.03 due to a non-cash gain on fair value of warrants. Operating expenses were $8.7M vs. $11.5M... More